David A. Eichenbaum, MD, FASRS, discusses findings on UBX-1325 for diabetic macular edema, highlighting a shift towards personalized, multi-mechanism therapies.
Dr David A. Eichenbaum
Advertisement
Articles by Dr David A. Eichenbaum
SD-OCT is providing reproducible, high-quality, registered images to assess the treatment response in macular disease.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Eye Care Network - Ophthalmology Times
1
FDA grants RMAT designation to Emmecell's EO2002 for corneal endothelial disease
2
NeuroOp Guru: What a big data study reveals about NAION and stroke risk
3
Port Delivery System Therapies in Retinal Vascular Diseases
4
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
5